GS
ADMS

Gagnon Securities’s Adamas Pharmaceuticals ADMS Stock Holding History

Gagnon Securities’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-12,415
Closed -$216K – 98
2014
Q4 		$216K Sell
12,415
-35
-0.3% -$531 0.07% 78
2014
Q3 		$232K Buy
12,450
+50
+0.4% +$860 0.08% 79
2014
Q2 		$227K Buy
+12,400
New +$222K 0.07% 76

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPH
C Partners Holding Zurich, Switzerland $317M AUM 4.76% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Securities's ADMS Position: Q1 2015 in Review

Gagnon Securities sold out of Adamas Pharmaceuticals (ADMS) in Q1 2015, closing a stake of 12,415 shares — an estimated $216K sold.

Gagnon Securities first reported a position in ADMS in Q2 2014 and held it in 3 quarters. The position peaked at $232K in Q3 2014. 63 funds tracked by Wall St. Rank hold ADMS as of Q1 2015.

  • Gagnon Securities reported no remaining Adamas Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Gagnon Securities sold 12,415 Adamas Pharmaceuticals shares in Q1 2015, an estimated $216K.
  • Gagnon Securities first reported a position in Adamas Pharmaceuticals in Q2 2014 and held it in 3 quarters.
  • Gagnon Securities's Adamas Pharmaceuticals position peaked at $232K in Q3 2014.
  • 63 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q1 2015.

Based on Gagnon Securities's 13F filing for Q1 2015, filed 12 May 2015.